Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
1,093.811,096.521,100.221,091.51
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
608.77608.77612.97608.77
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
1,254.811,253.011,253.871,226.33
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
1,761.111,764.271,766.881,744.71
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
642.58644.87648.48640.18
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
851.13855.66858.75845.56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
217.98217.98218.65216.88
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
3,211.833,227.213,268.383,226.55
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
948.98948.58957.83941.97
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
1,474.521,479.031,481.041,466.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
2,392.122,396.952,421.222,382.32
6185:HKG
Cansino Biologics Inc
HK$29.38
-1.54%
(-0.46) 1D
Apr 30, 4:08:11 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6185...
Open
HK$30.00
High
HK$30.00
Low
HK$29.24
Mkt. cap
12.07B
Avg. vol.
812.01K
Volume
852.20K
P/E ratio
226.66
52-wk high
HK$56.55
52-wk low
HK$29.24
EPS
HK$0.13
No. of employees
1K
News stories
From sources across the web
Profile
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
About Cansino Biologics Inc
CEOXuefeng Yu
Employees1.13K
FoundedJan 13, 2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
245.17M
310.24M
375.34M
190.28M
Cost of goods sold
54.74M
55.37M
129.82M
36.26M
Cost of revenue
54.74M
55.37M
129.82M
36.26M
Research and development expenses
75.08M
76.87M
88.37M
71.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
135.04M
158.60M
187.81M
116.85M
Operating expense
215.85M
218.49M
325.84M
178.95M
Total operating expenses
270.59M
273.86M
455.66M
215.21M
Operating income
-25.42M
36.38M
-80.32M
-24.93M
Other non operating income
743.94K
-8.06M
5.34M
-13.17M
EBT including unusual items
-2.71M
27.79M
13.25M
-34.38M
EBT excluding unusual items
-26.84M
40.15M
-74.47M
-36.51M
Income tax expense
-768.77K
-134.75K
-181.72K
6.04M
Effective tax rate
28.38%
-0.48%
-1.37%
-17.58%
Other operating expenses
2.44M
-15.79M
50.87M
-9.31M
Net income
-1.94M
27.93M
13.43M
-40.42M
Net profit margin
-0.79%
9.00%
3.58%
-21.24%
Earnings per share
-
-
-
-
Interest and investment income
19.08M
13.97M
21.09M
1.59M
Interest expense
-12.28M
-11.11M
-3.20M
-
Net interest expenses
6.80M
2.86M
17.88M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.74M
82.74M
-39.25M
16.15M
Gain or loss from assets sale
-84.72K
84.72K
-137.05K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more